增量腹膜透析与标准腹膜透析结果的比较:系统性审查和元分析

Shuang Xu1, Weifei Wu2, Jing Cheng3

  • 1Department of Nephrology and Urology, Huzhou Central Hospital, Affiliated Central Hospital HuZhou University, 1558 North Sanhuan Road, Huzhou, Zhejiang Province, 313000, China.

BMC nephrology
|September 16, 2024
PubMed
概括

增量腹膜透析 (IPD) 可能是标准全剂量腹膜透析 (SPD) 的安全替代方案,用于末期病患者. 该研究发现生存率或腹膜炎率没有显著差异,但残留功能 (RRF) 仍不清楚.